Lixte Biotech Hlds
(LIXT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2017 | 12-2014 | 12-2013 | 12-2006 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,599 | N/A | N/A | N/A | N/A |
| Receivables | 14 | N/A | N/A | N/A | N/A |
| TOTAL | $2,672 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $2,672 | $N/A | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 144 | 0 | 0 | 0 | 0 |
| Other current liabilities | 94 | N/A | N/A | N/A | N/A |
| TOTAL | $238 | $N/A | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $238 | $N/A | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | N/A | N/A | 45,576 | 41,583 | N/A |
| Common Shares | 1 | N/A | N/A | N/A | N/A |
| Retained earnings | -27,089 | N/A | N/A | N/A | N/A |
| TOTAL | $2,434 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $2,672 | $0 | $0 | $0 | $0 |